Logo

NHPBP

National Healthcare Properties, Inc.

NHPBP

National Healthcare Properties, Inc. • NASDAQ
$18.05 ▼ -0.55% (-0.10)
Market Cap $510.77 M
52w High $18.73
52w Low $11.77
Dividend Yield 1.78%
P/E 0
Volume 182
Outstanding Shares 28.30M

Income Statement

Period Revenue Operating Expense Net Income Net Profit Margin Earnings Per Share EBITDA
Q2-2025 $85.332M ▼ $37.002M ▲ $-20.803M ▼ -24.379% ▼ $0 $13.541M ▼
Q1-2025 $86.443M ▼ $15.879M ▼ $-1.569M ▲ -1.815% ▲ $0 $39.06M ▲
Q4-2024 $87.738M ▼ $34.202M ▼ $-16.988M ▲ -19.362% ▲ $0 $21.087M ▲
Q3-2024 $88.94M ▲ $53.459M ▼ $-40.692M ▲ -45.752% ▲ $0 $-2.042M ▲
Q2-2024 $88.817M $134.252M $-116.466M -131.13% $0 $-76.713M

Balance Statement

Period Cash & Short-term Total Assets Total Liabilities Total Equity
Q2-2025 $47.123M ▼ $1.759B ▼ $1.106B ▼ $647.033M ▼
Q1-2025 $71.383M ▲ $1.832B ▼ $1.152B ▼ $674.579M ▼
Q4-2024 $21.652M ▼ $1.946B ▼ $1.256B ▼ $684.56M ▼
Q3-2024 $32.858M ▲ $1.998B ▼ $1.289B ▼ $702.648M ▼
Q2-2024 $29.461M $2.113B $1.351B $756.745M

Cash Flow Statement

Period Net Income Cash From Operations Cash From Investing Cash From Financing Net Change Free Cash Flow
Q2-2025 $-20.834M ▼ $8.052M ▲ $-1.899M ▼ $-29.391M ▼ $-23.238M ▼ $1.356M ▲
Q1-2025 $-1.515M ▲ $-21.229M ▼ $78.043M ▲ $-4.501M ▲ $52.313M ▲ $-26.898M ▼
Q4-2024 $-17.026M ▲ $6.454M ▲ $5.409M ▼ $-22.68M ▼ $-10.817M ▼ $946K ▲
Q3-2024 $-40.769M ▲ $-95.235M ▼ $74.141M ▲ $25.033M ▲ $3.939M ▼ $-100.476M ▼
Q2-2024 $-116.918M $6.392M $-3.362M $1.529M $4.559M $393K

Five-Year Company Overview

Income Statement

Income Statement Revenue has been fairly steady over the past several years, inching up only slightly. The core rental and property income appears reasonably stable, and gross profit has held up in a narrow range, which suggests the underlying real estate assets continue to generate consistent top‑line performance. Below that, the picture is weaker. Operating profit has slipped from roughly break‑even to a clear loss in the most recent year, as costs and overhead outweigh the income from properties. Cash‑style earnings (EBITDA) were positive for several years but swung into the red most recently, and bottom‑line net income has been negative every single year, with losses deepening lately. Overall, this looks like a small, steady revenue base that is not yet covering its cost structure, with profitability trending the wrong way in the latest period.

Balance Sheet

Balance Sheet The balance sheet shows a sizable real estate asset base financed with a meaningful amount of debt and a shrinking equity cushion. Total assets have drifted down slightly over time, suggesting limited new growth and some gradual balance‑sheet contraction. Debt levels are high relative to equity and have not come down materially, so leverage remains a key feature of the capital structure. Equity has eroded as cumulative losses build up, which reduces the buffer available to absorb shocks. Cash on hand is quite thin and has fallen over the period, leaving limited liquidity if conditions worsen. In simple terms, this is a fairly levered balance sheet with modest flexibility and less room for error than a few years ago.

Cash Flow

Cash Flow Historically, the business generated modest positive cash flow from operations and covered its relatively light investment spending. That meant free cash flow hovered around break‑even to slightly positive for several years, indicating a self‑sustaining but not strongly cash‑generative profile. Most recently, this pattern broke down. Operating cash flow turned negative, and free cash flow moved clearly into the red. Capital spending itself is not large, so the issue is more about weaker cash earnings rather than heavy investment. This shift means the company has likely needed to lean more on debt, equity, or asset sales to fund itself, which adds pressure given the already leveraged balance sheet.

Competitive Edge

Competitive Edge Based on the description, this is (or was) a healthcare‑focused real estate owner, similar in profile to other healthcare REITs that lease out senior housing, medical offices, or care facilities. Those assets typically benefit from long‑term demographic tailwinds, such as an aging population and rising demand for outpatient and post‑acute care. However, two important caveats stand out. First, the entity tied to this ticker appears to be small and not actively traded today, which suggests limited scale, visibility, and access to capital compared with large listed healthcare REITs. Second, historical references point to corporate changes and an acquisition history, which can blur the current standalone competitive position. Overall, the business model sits in a structurally supported niche, but this specific vehicle does not show the size or financial strength that the leading players in the space enjoy.

Innovation and R&D

Innovation and R&D Traditional research and development is not a core activity for REITs, including healthcare REITs. Innovation tends to be more about how they use data, structure leases, and choose property types rather than about labs and patents. Background research suggests this name is tied to legacy National Health Properties, which was absorbed into a larger healthcare REIT (Ventas). At the big‑cap level, the sector’s innovation focus is on data‑driven site selection, partnering with strong operators, and developing specialized properties such as life‑science labs and university‑affiliated research centers. For this specific entity, direct information on its own innovation efforts is limited, and it is reasonable to treat its approach as broadly in line with standard healthcare REIT practices rather than a unique technology leader.

Summary

Putting it all together, the financial profile here is one of a small healthcare real estate vehicle with stable but modest revenue, persistent net losses, and recent deterioration in both profitability and cash generation. The asset base is meaningful but funded with substantial debt and a dwindling equity cushion, while cash balances are thin. This combination leaves the structure sensitive to interest costs, refinancing conditions, and any hit to property cash flows. On the positive side, the underlying sector—healthcare and senior‑oriented real estate—benefits from long‑term demographic trends. But the available data show that this particular vehicle has not yet converted those structural tailwinds into durable profits or strong free cash flow, and information about its current corporate status and strategy is limited. Any interpretation of its prospects should therefore be made with caution, keeping both the sector advantages and the balance‑sheet and earnings pressures in mind.

NEWS

November 5, 2025 · 4:52 PM UTC

National Healthcare Properties Reports Third Quarter 2025 Results

Read more

October 29, 2025 · 7:38 PM UTC

National Healthcare Properties Announces Release Date for Third Quarter 2025 Results

Read more

September 19, 2025 · 6:44 PM UTC

National Healthcare Properties Announces Preferred Stock Dividends

Read more